Autopsy report · NCT02669303

Platelet-rich Plasma (PRP) Injection for Treating Shoulder Subacromial Impingement Syndrome

“low recruitment rate and high rate of loss-to-followup”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 4 months before it stopped.
• 19 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

American University of Beirut Medical Center

Sponsor type

University, hospital or other

Conditions

Shoulder Impingement Syndrome

Interventions

platelet-rich plasma group; Methylprednisolone group

Participants

19

Sites

1

Countries

Lebanon

Trials that died the same way

• Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI)
  “Due to the low recruitment rate and the large number lost to follow-up” (82% match in meaning)
• Effect of Different Electric Muscle Stimulation in Patients With Severe Sepsis and Respiratory Failure
  “slow recruitment and high drop-out rate” (81% match in meaning)
• Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy
  “low recruitment rate” (79% match in meaning)
• Cerebral Autoregulation in Non Neurological Critical Patients.
  “Slow recruitment rate” (75% match in meaning)
• NHFOV Versus NCPAP to Prevent Exubation Failure
  “Poor recruitment rate” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.